• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

Adar Poonawalla sells stake in Panacea Biotec

expresspharmaMay 19, 2021

Tag: Adar , SII , Panacea Biotec

Adar Poonawalla, CEO, Serum Institute of India (SII) has sold off his entire stake of 31,57,034 shares in Panacea Biotec at a price of Rs 373.85 apiece. He had a 5.15 per cent shareholding in the company and the total value of the transaction was a little over Rs 118 crores. The stake was picked up by SII.

PTI reported that as per shareholding data for March quarter, Poonawalla and SII were public shareholders in the company. They held 5.15 per cent and 4.98 per cent stake respectively in Panacea Biotec.

Previous:Good News in the Chinese Diabetes Field and Several Original Research Drugs Underway

Next:Boehringer Ingelheim allocates one million Euros to fight COVID-19 in India

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Adar Poonawalla sells stake in Panacea Biotec | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

Cosmosiin 98%

Cosmosiin 98%
100%Nutramax Supplier -sambucus williamsii hance extract10:1

100%Nutramax Supplier -sambucus williamsii hance extract10:1
Herba Cirsii Extract

Herba Cirsii Extract
Losartan potassium (ProcessII)

Losartan potassium (ProcessII)
elder Sambucus williamsii Sambucus nigra Williams Elder Twig elderberry extract elder Sambucus willi

elder Sambucus williamsii Sambucus nigra Williams Elder Twig elderberry extract elder Sambucus willi
PHENOXYMETHYL PENICILLIN POTASSIUM

PHENOXYMETHYL PENICILLIN POTASSIUM
LINCOMYCIN HCL

LINCOMYCIN HCL
GENTAMYCIN SULPHATE macrolides

GENTAMYCIN SULPHATE macrolides
CEFALEXINE cephalosporins

CEFALEXINE cephalosporins
CEFRADINE cephalosporins

CEFRADINE cephalosporins

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service